Headquarters
1400 SIERRA POINT PKWY STE 200, BRISBANE, CA 94005-1808, US
BRISBANE, CA, US
From the company
Annexon Biosciences is a clinical-stage biopharmaceutical company focused on stopping C1q, the initiating molecule of the classical complement pathway, to treat autoimmune, neurodegenerative, and ophthalmic diseases of the body, brain and eye. It was co-founded by Dr. Ben Barres and Dr. Arnon Rosenthal and has a late-stage clinical pipeline of therapies targeting complement-mediated diseases.
1400 SIERRA POINT PKWY STE 200, BRISBANE, CA 94005-1808, US
Quantities, certifications, and timing.